Showing results (91-100 of 148) with videos related to

Sort By:
Pageof 15
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 7, 2020
Phylogenetic diversity of Mycobacterium tuberculosis in two geographically distinct locations in Botswana - The Kopanyo StudyEleanor S Click, Alyssa Finlay, John E Oeltmann, et al.
Mayo Clinic Proceedings|August 5, 2008
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney diseaseJames Shepherd, John P Kastelein, Vera A Bittner, et al.
The Lancet. Diabetes & Endocrinology|July 15, 2019
Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statementIan J Neeland, Robert Ross, Jean-Pierre Després, et al.
Nature Reviews. Endocrinology|February 6, 2020
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral ObesityRobert Ross, Ian J Neeland, Shizuya Yamashita, et al.
Circulation|June 4, 2008
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatmentJohn J P Kastelein, Wim A van der Steeg, Ingar Holme, et al.
Atherosclerosis|December 17, 2009
Lipoprotein-associated phospholipase A(2), inflammatory biomarkers, and risk of cardiovascular disease in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Muriel J Caslake, Chris J Packard, Michele Robertson, et al.
Circulation|July 16, 2003
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention StudyNaveed Sattar, Allan Gaw, Olga Scherbakova, et al.
Circulation|September 15, 2004
Effect of pravastatin on cardiovascular events in people with chronic kidney diseaseMarcello Tonelli, Chris Isles, Gary C Curhan, et al.
European Heart Journal|May 1, 2014
Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trialJean-Claude Tardif, Christie M Ballantyne, Philip Barter, et al.
BMC Infectious Diseases|October 27, 2016
Implementation of a pragmatic, stepped-wedge cluster randomized trial to evaluate impact of Botswana's Xpert MTB/RIF diagnostic algorithm on TB diagnostic sensitivity and early antiretroviral therapy mortalityAndrew F Auld, Tefera Agizew, Sherri Pals, et al.
Pageof 15